Ultragenyx Pharmaceutical, Inc. (RARE)
24.77
+0.08
(+0.32%)
USD |
NASDAQ |
May 01, 16:00
24.76
-0.01
(-0.04%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Total Liabilities (Quarterly) : 1.605B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Xencor, Inc. | 239.91M |
| REGENXBIO, Inc. | 350.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.532B |
| Shareholders Equity (Quarterly) | -80.00M |
| Debt to Equity Ratio | -15.65 |
| Current Ratio | 2.477 |
| Net Debt Paydown Yield | -3.06% |